ISTH/LinkedIn
Aug 14, 2026, 06:26
Delivering Gene Therapy in Hemophilia – ISTH
International Society on Thrombosis and Haemostasis (ISTH) shared on LinkedIn:
“Delivering gene therapy in hemophilia isn’t just a clinical decision, it’s an operational one. From referral pathways to long-term monitoring, successful implementation requires coordination across teams, systems, and care models.
Our new resource builder helps you not only navigate referral, preparation, and administration workflows, but grants you access to tools tailored to your region and practice setting.
Support your team in managing the complexities of gene therapy by building a personalized set of implementation resources and taking the next step toward integrating gene therapy into practice!”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate
-
Sep 29, 2026, 10:54How Does Haemophilia Affect Motor Development in Infants? – EAHAD
-
Sep 29, 2026, 10:49Alison Davey: The Vital Role of Community Support in Bleeding Disorders
-
Sep 29, 2026, 10:36Abdul Muqtadir Abbasi: 5 Questions to Ask When the CBC Is Abnormal
-
Sep 29, 2026, 10:28Manu Morales Sánchez: DOACs in Intermediate Risk Atrial Fibrillation
-
Sep 29, 2026, 09:59William Sauer: Ablation in Patients With LAAO Devices
-
Sep 29, 2026, 03:53Nahrwan Masaoodi: Iron Deficiency Can Exist Without Anemia